GLOBAL PAIN MANAGEMENT DRUGS MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • GLOBAL PAIN MANAGEMENT DRUGS MARKET FORECAST 2019-2027

GLOBAL PAIN MANAGEMENT DRUGS MARKET FORECAST 2019-2027

The global pain management drugs market is anticipated to grow at a CAGR of 3.88% between 2019 and 2027. Rise in geriatric population is the major factor that drives the growth of the global pain management market, as aged people are more prone to suffer from joint pain and other chronic conditions. The following factors are primarily driving the pain management drugs market:

GLOBAL PAIN MANAGEMENT DRUGS MARKET FORECAST 2019-2027

Global Pain Management Drugs Market by Drug Class (Nsaids, Anesthetics, Anticonvulsants, Anti-migraine Agents, Antidepressants, Opioids, Non-narcotic Analgesics), Market by (Indication, Arthriticpain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Post-operative Pain, Migraine, Fibromyalgia) & by Geography.

Request free sample

The global pain management drugs market is anticipated to grow at a CAGR of 3.88% between 2019 and 2027. Rise in geriatric population is the major factor that drives the growth of the global pain management market, as aged people are more prone to suffer from joint pain and other chronic conditions. The following factors are primarily driving the pain management drugs market:

  • Growth in the incidence and prevalence of chronic diseases
  • The rise in awareness regarding the side-effects of pain medication
  • Rise in geriatric population size

The important drivers increasing growth in the global pain management drugs market are the increasing occurrences of chronic diseases and rise in the geriatric population. The higher the chronic diseases occur, such as heart disease, stroke, type II diabetes, and cancer, the higher will be the sales of the said market for its product which will furthermore drive the pain management drugs market growth. The rise in geriatric population could also increase the usage of pain medications, thus, boosting the market growth.

The drug class of pain management drugs market is mainly employed for pain management treatment. The growing demand for NSAIDs has led to an increase in the emergence of new products in the market that uses NSAID components. An anesthetic is a drug used to prevent the feeling of pain during surgery. Anticonvulsants are used extensively for the treatment of fibromyalgia, migraine and neuropathic pain. An antimigraine drug is a medication designed to reduce the effects or intensity of a migraine headache. Antidepressants could be used to treat pain caused by a migraine, arthritis, low back pain, peripheral neuropathy and others. Opioids are narcotic drugs and mostly indicated for the pain management. The drugs act on both the central nervous system and peripheral nervous system. The opioid drugs are associated with several side effects such as mental fog, drowsiness, constipation and nausea. Non-narcotic analgesics are used to treat persistent or acute pains. They are mainly used for the treatment of mild to moderate pain; however, these drugs can be used in combination with other medications or therapies to treat moderate to severe pain.

Accessibility of alternative therapies and an increase in drug mistreatment are the major factors hindering the progress of the pain management drugs market. Alternative therapies are gaining popularity in recent times as they cause fewer side-effects and more effective at alleviating pain as compared to drugs. Increase in drug mistreatment has increased the stringency of regulatory authorities for the development of drugs.

The global pain management drugs market segments include drug class and indication.

Drug class is segmented into:

  • Anesthetics
  • Opioids
  • Anticonvulsants
  • NSAIDs
  • Antidepressants
  • Anti-migraine agents
  • Non-narcotic analgesics

Indication is segmented into:

  • Fibromyalgia
  • Neuropathic pain
  • Cancer pain
  • Arthritic pain
  • Post-operative pain
  • Migraine
  • Chronic back pain

This report covered the present market conditions and the growth prospects of the global pain management drugs market for 2019-2027 and considered the revenue generated through the sales of pain management drugs for the segments of drug class and indication to calculate the market size by considering 2018 as the base year.

Geographically, the global pain management drugs market has been segmented into four major regions, which include:

  • North America: The United States & Canada
  • Asia-Pacific: China, India, Japan, Australia, South Korea & Rest of APAC
  • Europe: The United Kingdom, France, Germany, Italy, Spain & Rest of Europe
  • Rest of World: Latin America & the Middle East and Africa

The pain management drugs market in North America is expected to hold the largest share by 2027 because of major possibilities of the rising frequency of drug abuse cases. The addictive nature of opioids has also decreased the use of opioid as a prescription drug in the North American region, leading to a decline in opioid consumption as medicine in this region for pain management. The presence of a large patient population suffering from pain also boosted the market growth. The rate of a drug overdose has been increased in Canada, coincidently due to the higher prescription rate of opioid drugs that is furthermore driving the market growth for pain management market.

On the other hand, the Asia-Pacific market is anticipated to be the fastest-growing region for the pain management drugs market. This is mainly attributable to the presence of a larger patient pool and the increase in healthcare expenditure in this region. Japan is the largest contributor towards the Asia-Pacific market. China and India are among the fastest growing pain management drugs markets in the region.

The pain management drugs market is segmented on the basis of indication which is sub-divided into neuropathic pain, migraine, chronic back pain, cancer pain, arthritic pain, post-operative pain and fibromyalgia. Problems associated with aches and pain caused in joints are occurring mainly because of arthritis. Neuropathic pain is usually caused due to damage or disease that affects the somatosensory nervous system. Cancer pain is frequently caused by the tumorous tissue growth in the bones, nerves or other organs in the body. Due to the growing demand of remedies for chronic backaches, there is an increase in the governmental support to speed up the approval process for medications and provide help to patients with improved prescription drugs. Post-operative pain is usually caused after the patient undergoes through some form of surgeries. A migraine is a type of headache-related malady with sensitivity towards odor, light or acoustics. Fibromyalgia is a common type of chronic pain where the patient suffers from musculoskeletal pain along with memory, fatigue, sleep and mood issues.

The major market players of the global pain management drugs market are:

  • Pfizer, Inc.
  • Purdue Pharma L.P.
  • Eli Lilly And Company
  • GlaxoSmithKline
  • Johnson & Johnson

Company Profiles covers analysis of important players.

Pfizer, Inc. is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines as well as consumer healthcare products. Johnson & Johnson conducts its international business through more than 250 operating companies across the globe. It has major operations in the Americas, Europe, Asia Pacific and Africa.

Key findings of the global pain management drugs market:

  • Opioids market holds the largest market share in terms of the drug class
  • Cancer pain indication is anticipated to grow at a significant rate
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • OPIOIDS MARKET HOLDS THE LARGEST MARKET SHARE IN TERMS OF DRUG CLASS
      • CANCER PAIN INDICATION IS ANTICIPATED TO GROW AT A SIGNIFICANT RATE
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • GROWTH IN THE INCIDENCE AND PREVALENCE OF CHRONIC DISEASES
      • THE RISE IN AWARENESS REGARDING THE SIDE-EFFECTS OF PAIN MEDICATION
      • RISE IN GERIATRIC POPULATION
    • MARKET RESTRAINTS
      • ACCESSIBILITY OF ALTERNATIVE THERAPIES
      • INCREASE IN DRUG MISTREATMENT
    • MARKET OPPORTUNITIES
      • TECHNOLOGICAL ADVANCEMENT
      • GROWTH POTENTIAL IN UNTAPPED ECONOMIES
    • MARKET CHALLENGES
      • PATENT EXPIRATION
  1. MARKET BY DRUG CLASS
    • NSAIDS
    • ANESTHETICS
    • ANTICONVULSANTS
    • ANTI-MIGRAINE AGENTS
    • ANTIDEPRESSANTS
    • OPIOIDS
    • NON-NARCOTIC ANALGESICS
  2. MARKET BY INDICATION
    • ARTHRITIC PAIN
    • NEUROPATHIC PAIN
    • CANCER PAIN
    • CHRONIC BACK PAIN
    • POST-OPERATIVE PAIN
    • MIGRAINE
    • FIBROMYALGIA
  3. KEY ANALYTICS
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • THREAT OF COMPETITIVE RIVALRY
    • REGULATORY FRAMEWORK
    • OPPORTUNITY MATRIX
    • VALUE CHAIN ANALYSIS
    • VENDOR LANDSCAPE
  4. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA-PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA
  1. COMPETITIVE LANDSCAPE
    • MARKET SHARE ANALYSIS
    • COMPANY PROFILES
      • ABBOTT LABORATORIES
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • ACURA PHARMACEUTICALS, INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • CIPHER PHARMACEUTICALS INC.
        • COMPANY PROFILES
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • DAIICHI SANKYO, INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • EGALET CORP.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • ELI LILLY AND COMPANY
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • GLAXOSMITHKLINE
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • HIKMA PHARMACEUTICALS PLC
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • JOHNSON & JOHNSON
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • LUPIN LTD.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • PFIZER, INC.
        • COMPANY PROFILES
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • PURDUE PHARMA L.P.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • MERCK & CO., INC.
        • COMPANY PROFILES
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • NOVARTIS
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • INSYS THERAPEUTICS, INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES

LIST OF TABLES

TABLE 1       GLOBAL PAIN MANAGEMENT DRUGS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 2       GLOBAL PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)

TABLE 3       GLOBAL NSAIDS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 4       GLOBAL ANESTHETICS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 5       GLOBAL ANTICONVULSANTS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 6       GLOBAL ANTI-MIGRAINE AGENTS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 7       GLOBAL ANTIDEPRESSANTS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 8       GLOBAL OPIOIDS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 9       GLOBAL NON-NARCOTIC ANALGESICS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 10     GLOBAL PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)

TABLE 11     GLOBAL ARTHRITIC PAIN MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 12     GLOBAL NEUROPATHIC PAIN MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 13     GLOBAL CANCER PAIN MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 14     GLOBAL CHRONIC BACK PAIN MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 15     GLOBAL POST-OPERATIVE PAIN MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 16     GLOBAL MIGRAINE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 17     GLOBAL FIBROMYALGIA MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 18     GLOBAL PAIN MANAGEMENT DRUGS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 19     NORTH AMERICA PAIN MANAGEMENT DRUGS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 20     THE UNITED STATES PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)

TABLE 21     THE UNITED STATES PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)

TABLE 22     CANADA PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)

TABLE 23     CANADA PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)

TABLE 24     EUROPE PAIN MANAGEMENT DRUGS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 25     GERMANY PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)

TABLE 26     GERMANY PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)

TABLE 27     FRANCE PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)

TABLE 28     FRANCE PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)

TABLE 29     THE UNITED KINGDOM PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)

TABLE 30     THE UNITED KINGDOM PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)

TABLE 31     ITALY PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)

TABLE 32     ITALY PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)

TABLE 33     SPAIN PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)

TABLE 34     SPAIN PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)

TABLE 35     ASIA-PACIFIC PAIN MANAGEMENT DRUGS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 36     JAPAN PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)

TABLE 37     JAPAN PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)

TABLE 38     CHINA PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)

TABLE 39     CHINA PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)

TABLE 40     INDIA PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)

TABLE 41     INDIA PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)

TABLE 42     AUSTRALIA PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)

TABLE 43     AUSTRALIA PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)

TABLE 44     SOUTH KOREA PAIN MANAGEMENT DRUGS MARKET BY DRUG CLASS 2019-2027 ($ MILLION)

TABLE 45     SOUTH KOREA PAIN MANAGEMENT DRUGS MARKET BY INDICATION 2019-2027 ($ MILLION)

TABLE 46     REST OF WORLD PAIN MANAGEMENT DRUGS MARKET BY COUNTRY 2019-2027 ($ MILLION)

LIST OF FIGURES

FIGURE 1     GLOBAL PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 2     GLOBAL PAIN MANAGEMENT DRUGS MARKET SHARE BY DRUG CLASS 2018 & 2027 (%)

FIGURE 3     GLOBAL PAIN MANAGEMENT DRUGS MARKET BY NSAIDS 2019-2027 ($ MILLION)

FIGURE 4     GLOBAL PAIN MANAGEMENT DRUGS MARKET BY ANESTHETICS 2019-2027 ($ MILLION)

FIGURE 5     GLOBAL PAIN MANAGEMENT DRUGS MARKET BY ANTICONVULSANTS 2019-2027 ($ MILLION)

FIGURE 6     GLOBAL PAIN MANAGEMENT DRUGS MARKET BY ANTI-MIGRAINE AGENTS 2019-2027 ($ MILLION)

FIGURE 7     GLOBAL PAIN MANAGEMENT DRUGS MARKET BY ANTIDEPRESSANTS 2019-2027 ($ MILLION)

FIGURE 8     GLOBAL PAIN MANAGEMENT DRUGS MARKET BY OPIOIDS 2019-2027 ($ MILLION)

FIGURE 9     GLOBAL PAIN MANAGEMENT DRUGS MARKET BY NON-NARCOTIC ANALGESICS 2019-2027 ($ MILLION)

FIGURE 10   GLOBAL PAIN MANAGEMENT DRUGS MARKET SHARE BY INDICATION 2018 & 2027 (%)

FIGURE 11   GLOBAL PAIN MANAGEMENT DRUGS MARKET BY ARTHRITIC PAIN 2019-2027 ($ MILLION)

FIGURE 12   GLOBAL PAIN MANAGEMENT DRUGS MARKET BY NEUROPATHIC PAIN 2019-2027 ($ MILLION)

FIGURE 13   GLOBAL PAIN MANAGEMENT DRUGS MARKET BY CANCER PAIN 2019-2027 ($ MILLION)

FIGURE 14   GLOBAL PAIN MANAGEMENT DRUGS MARKET BY CHRONIC BACK PAIN 2019-2027 ($ MILLION)

FIGURE 15   GLOBAL PAIN MANAGEMENT DRUGS MARKET BY POST-OPERATIVE PAIN 2019-2027 ($ MILLION)

FIGURE 16   GLOBAL PAIN MANAGEMENT DRUGS MARKET BY MIGRAINE 2019-2027 ($ MILLION)

FIGURE 17   GLOBAL PAIN MANAGEMENT DRUGS MARKET BY FIBROMYALGIA 2019-2027 ($ MILLION)

FIGURE 18   PORTER’S FIVE FORCE MODEL

FIGURE 19   GLOBAL PAIN MANAGEMENT DRUGS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE 20   THE UNITED STATES PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 21   CANADA PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 22   GERMANY PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 23   FRANCE PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 24   THE UNITED KINGDOM PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 25   ITALY PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 26   SPAIN PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 27   REST OF EUROPE PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 28   JAPAN PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 29   CHINA PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 30   INDIA PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 31   AUSTRALIA PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 32   SOUTH KOREA PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 33   REST OF ASIA-PACIFIC PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 34   LATIN AMERICA PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 35   MIDDLE EAST AND AFRICA PAIN MANAGEMENT DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 36   PAIN MANAGEMENT MARKET SHARE ANALYSIS 2017 (%)

  1. MARKET BY DRUG CLASS
    • NSAIDS
    • ANESTHETICS
    • ANTICONVULSANTS
    • ANTI-MIGRAINE AGENTS
    • ANTIDEPRESSANTS
    • OPIOIDS
    • NON-NARCOTIC ANALGESICS
  2. MARKET BY INDICATION
    • ARTHRITIC PAIN
    • NEUROPATHIC PAIN
    • CANCER PAIN
    • CHRONIC BACK PAIN
    • POST-OPERATIVE PAIN
    • MIGRAINE
    • FIBROMYALGIA
  3. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA-PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now